Anders Goransson - Bactiguard Holding Chief Officer
| BACTI-B Stock | SEK 35.00 6.30 1.14% |
Insider
Anders Goransson is Chief Officer of Bactiguard Holding AB
| Age | 52 |
| Phone | 46 84 40 58 80 |
| Web | https://www.bactiguard.com |
Bactiguard Holding Management Efficiency
The company has return on total asset (ROA) of (0.0369) % which means that it has lost $0.0369 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.102) %, meaning that it generated substantial loss on money invested by shareholders. Bactiguard Holding's management efficiency ratios could be used to measure how well Bactiguard Holding manages its routine affairs as well as how well it operates its assets and liabilities.Bactiguard Holding AB has accumulated 238.31 M in total debt with debt to equity ratio (D/E) of 65.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Bactiguard Holding has a current ratio of 1.64, which is within standard range for the sector. Debt can assist Bactiguard Holding until it has trouble settling it off, either with new capital or with free cash flow. So, Bactiguard Holding's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bactiguard Holding sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bactiguard to invest in growth at high rates of return. When we think about Bactiguard Holding's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Michael Roth | Bonesupport Holding AB | 60 | |
| Petra Duprez | Biotage AB | 58 | |
| Lars LLB | Biotage AB | 62 | |
| Prof MD | Bonesupport Holding AB | 80 | |
| Michael MD | Bonesupport Holding AB | 49 | |
| JonSverre Schanche | Biotage AB | 66 | |
| Maths hc | CellaVision AB | 57 | |
| CS BSc | Biotage AB | 50 | |
| Scott Carr | Biotage AB | 56 | |
| Nina Wallander | CellaVision AB | 49 | |
| Raffaella Bombarda | Biotage AB | 49 | |
| Olof Nord | Biotage AB | 48 | |
| Tomas Blomquist | Biotage AB | 53 | |
| Fergus MacLeod | Bonesupport Holding AB | 53 | |
| Simon Ostergaard | CellaVision AB | 52 | |
| Yve Thorenburg | CellaVision AB | 65 | |
| Julien Veyssy | CellaVision AB | 40 | |
| Hkan Johansson | Bonesupport Holding AB | 60 | |
| Kristina Ingvar | Bonesupport Holding AB | 51 | |
| AnnMarie Thor | Bonesupport Holding AB | N/A | |
| Maja Nilsson | Biotage AB | N/A | |
Management Performance
| Return On Equity | -0.1 | |||
| Return On Asset | -0.0369 |
Bactiguard Holding Leadership Team
Elected by the shareholders, the Bactiguard Holding's board of directors comprises two types of representatives: Bactiguard Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bactiguard. The board's role is to monitor Bactiguard Holding's management team and ensure that shareholders' interests are well served. Bactiguard Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bactiguard Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sathish Subramaniam, Chief Officer | ||
| Carin Jakobson, Chief Officer | ||
| Peter Radqvist, Head Sales | ||
| Stefan Grass, Deputy Officer | ||
| Anders Goransson, Chief Officer | ||
| Carl Fredin, Chief Officer |
Bactiguard Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bactiguard Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.1 | |||
| Return On Asset | -0.0369 | |||
| Profit Margin | (0.23) % | |||
| Operating Margin | (0.21) % | |||
| Current Valuation | 3.96 B | |||
| Shares Outstanding | 31.04 M | |||
| Shares Owned By Insiders | 44.20 % | |||
| Shares Owned By Institutions | 39.71 % | |||
| Price To Earning | (75.59) X | |||
| Price To Book | 7.68 X |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Bactiguard Stock
Bactiguard Holding financial ratios help investors to determine whether Bactiguard Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bactiguard with respect to the benefits of owning Bactiguard Holding security.